These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8972557)
1. Castanospermine, an oligosaccharide processing inhibitor, reduces membrane expression of adhesion molecules and prolongs heart allograft survival in rats. Grochowicz PM; Hibberd AD; Smart YC; Bowen KM; Clark DA; Cowden WB; Willenborg DO Transpl Immunol; 1996 Dec; 4(4):275-85. PubMed ID: 8972557 [TBL] [Abstract][Full Text] [Related]
2. Castanospermine, an oligosaccharide-processing inhibitor, reduces membrane expression of adhesion molecules and prolongs heart allograft survival in rats. Hibberd AD; Grochowicz PM; Smart YC; Bowen KM; Clark DA; Cowden WB; Willenborg DO Transplant Proc; 1997; 29(1-2):1257-8. PubMed ID: 9123295 [No Abstract] [Full Text] [Related]
3. The effects of Castanospermine, an oligosaccharide processing inhibitor, on mononuclear/endothelial cell binding and the expression of cell adhesion molecules. Hibberd AD; Trevillian PR; Clark DA; McElduff P; Cowden WB Transpl Immunol; 2012 Aug; 27(1):39-47. PubMed ID: 22647882 [TBL] [Abstract][Full Text] [Related]
4. Castanospermine modifies expression of adhesion molecules in allograft recipients. Grochowicz PM; Smart YC; Bowen KM; Hibberd AD; Clark DA; Cowden WB; Willenborg DO Transplant Proc; 1993 Oct; 25(5):2900-1. PubMed ID: 8105589 [No Abstract] [Full Text] [Related]
6. Methotrexate regulates ICAM-1 expression in recipients of rat cardiac allografts. Ciesielski CJ; Pflug JJ; Mei J; Piccinini LA Transpl Immunol; 1998 Jun; 6(2):111-21. PubMed ID: 9777700 [TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. Grochowicz PM; Hibberd AD; Bowen KM; Clark DA; Pang G; Cowden WB; Chou TC; Grochowicz LK; Smart YC Transplant Proc; 1997; 29(1-2):1259-60. PubMed ID: 9123296 [No Abstract] [Full Text] [Related]
8. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916 [No Abstract] [Full Text] [Related]
9. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. Miwa S; Isobe M; Suzuki J; Makuuchi M; Miyasaka M; Yamazaki S; Kawasaki S Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469 [TBL] [Abstract][Full Text] [Related]
10. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of adhesion molecules during rat small bowel allograft rejection. Reid SD; Uff CR; Saeed I; Ross J; Wood RF; Pockley AG Transplantation; 1995 Nov; 60(9):989-92. PubMed ID: 7491706 [TBL] [Abstract][Full Text] [Related]
12. Sequential analysis of adhesion molecules and their ligands in rat renal allografts during the development of chronic rejection. Kauppinen H; Soots A; Krogerus L; Loginov R; Holma K; Ahonen J; Lautenschlager I Transpl Int; 2000; 13(4):247-54. PubMed ID: 10959476 [TBL] [Abstract][Full Text] [Related]
13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
15. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats. Harrison PC; Madwed JB J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890 [TBL] [Abstract][Full Text] [Related]
16. Castanospermine, an oligosaccharide processing inhibitor, reduces both lymphocyte-endothelial cell binding and LFA-1alpha membrane expression. Clark DA; Hibberd AD; Trevillian PR; Cowden WB Transplant Proc; 2001; 33(1-2):522. PubMed ID: 11266936 [No Abstract] [Full Text] [Related]
17. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade. Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Blaheta RA; Leckel K; Wittig B; Zenker D; Oppermann E; Harder S; Scholz M; Weber S; Schuldes H; Encke A; Markus BH Transpl Immunol; 1998 Dec; 6(4):251-9. PubMed ID: 10342739 [TBL] [Abstract][Full Text] [Related]
19. Blood lymphocytes, monocytes and NK cells modulate their expression of CD44, ICAM-1, LFA-1 and MHC class II after arrival into lymphoid organs. Milićević NM; Nohroudi K; Milićević Z; Westermann J Immunol Invest; 2004; 33(4):439-52. PubMed ID: 15624701 [TBL] [Abstract][Full Text] [Related]
20. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914 [No Abstract] [Full Text] [Related] [Next] [New Search]